MOTS-c: A Mitochondrial Peptide for Metabolic and Cardiovascular Health

by Dr. James Ross

Disclaimer: All articles and product details provided on this website are intended for educational and informational purposes only. The products listed here are for in-vitro research only. In-vitro studies are conducted outside of living organisms. These products are not intended as medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. The direct or indirect administration of these substances to humans or animals is unequivocally prohibited under applicable law.

Introduction: Mitochondria and the Aging Process

Aging is accompanied by a steady decline in physiological performance. This process reflects a complex interplay between environmental and genetic factors, with mitochondrial function emerging as a central regulator. Beyond energy production, mitochondria influence inflammation, oxidative balance, proteostasis, stem cell activity, and adaptive stress responses.

A growing body of research highlights the role of mitochondrial-derived peptides (MDPs)—also called mitokines—in coordinating communication between mitochondria, the nucleus, and the wider cell environment. Among these, MOTS-c has gained particular attention for its ability to regulate metabolism, stress resistance, and cardiovascular function.

What Is MOTS-c?

MOTS-c is a 16–amino acid peptide encoded within the mitochondrial 12S rRNA gene. Unlike many peptides that act locally, MOTS-c can translocate into the nucleus under conditions of metabolic stress. Once inside the nucleus, it regulates gene expression—particularly genes with antioxidant response elements (AREs)—to bolster stress resistance.

This mechanism may explain why exogenous MOTS-c can counteract diet-induced obesity, insulin resistance, and age-related metabolic decline, while having little effect on baseline metabolism in young, healthy subjects.

MOTS-c as a Regulator of Physical Function and Muscle Homeostasis

In mice, systemic MOTS-c treatment has been shown to double treadmill performance across all age groups. Its effects include:

• Regulation of nuclear genes tied to metabolism and protein homeostasis 
• Support for glucose and amino acid metabolism in skeletal muscle 
• Enhanced myoblast survival under metabolic stress 

These benefits are linked to activation of HSF1 (heat shock factor 1). When HSF1 is silenced, MOTS-c loses its ability to protect cells under glucose or nutrient restriction, showing that HSF1 is a key mediator of MOTS-c function.

Long-term experiments suggest MOTS-c may even extend healthspan, delaying physical decline when administered late in life. Importantly, exercise itself induces MOTS-c expression, suggesting the peptide plays a role in the adaptive response to physical stress.

MOTS-c Levels and Muscle Fiber Composition

Human studies reveal that plasma MOTS-c levels decline with age, while muscle tissue levels increase. For example, men aged 70–81 show ~21% lower plasma levels than young adults, despite higher muscle expression.

This discrepancy is partly explained by a shift in muscle fiber type: aging promotes a transition from fast-twitch to slow-twitch fibers, which have higher mitochondrial density. MOTS-c levels positively correlate with slow-fiber markers (MYH7) and negatively with fast-fiber markers (MYH2).

Thus, MOTS-c may help preserve muscle homeostasis by supporting the energy-demanding slow fibers that dominate with age.

MOTS-c and Endothelial Function

Low circulating MOTS-c is associated with coronary endothelial dysfunction in humans. In animal models, MOTS-c pretreatment enhances vascular responsiveness to acetylcholine, improving blood vessel relaxation.

Although it does not act as a direct vasodilator, MOTS-c reduces endothelial dysfunction through anti-inflammatory effects—dampening cytokine release and adhesion molecule expression, largely via NF-κB inhibition.

Cardiovascular Protection and Longevity

Through activation of AMP-activated protein kinase (AMPK), MOTS-c boosts:

• Glucose uptake and utilization
• Fatty acid oxidation
• Energy efficiency

This AMPK-mediated action helps counter insulin resistance, diabetes, and obesity. At the same time, its nuclear signaling role promotes resilience against oxidative stress and metabolic imbalance.

Notably, populations with genetic variants in the MOTS-c coding region (e.g., the m.1382A>C SNP found in long-lived Japanese cohorts) appear to benefit from enhanced MOTS-c function—linking this peptide to human longevity.

REFERENCES

1. The Mitochondrial-Derived Peptide MOTS-c Promotes Metabolic Homeostasis and Reduces Obesity and Insulin Resistance
2. D’Souza RF, Woodhead JST, Hedges CP, Zeng N, Wan J, Kumagai H, Lee C, Cohen P, Cameron-Smith D, Mitchell CJ, Merry TL. Increased expression of the mitochondrial derived peptide, MOTS-c, in skeletal muscle of healthy aging men is associated with myofiber composition. Aging (Albany NY). 2020 Mar 17;12(6):5244-5258. doi: 10.18632/aging.102944. Epub 2020 Mar 17. PMID: 32182209; PMCID: PMC7138593.

Product available for research use only: